Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

Biden Asked OPEC+ To Delay Output Decision, Elon Musk Faces Federal Probe Over Twitter Deal, Netflix Ad-Supported Plan: Top Stories Friday, Oct. 14

Reuters Twitter Says Elon Musk Under Federal Probe Over $44B Twitter Deal, In Court Filing

Benzinga · Oct 14, 2022

EU regulator recommends clearing Takeda's dengue vaccine

The European Medicines Agency is recommending that a dengue vaccine made by the Japanese pharmaceutical Takeda be authorized, in a move that could provide a new tool for millions worldwide against the potentially fatal disease

The Independent UK · Oct 14, 2022

How long can you test positive for Covid and when are you infectious?

A surge in cases is indicating a new wave has started in the UK

The Independent UK · Oct 14, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Warning of new Covid strain 'Omicron Spawn' - here are the symptoms

The prevalence of BF.7 has doubled in the United States over the past two weeks, rising from 0.8% to 1.7%

Dublin Live · Oct 14, 2022

Amateur chemist played 'key role' in gang's plot to flood country with drugs

Laszlo Viszocsanszki, 56, played an 'essential' role in a scheme to flood the UK with the drug.

Manchester Evening News · Oct 14, 2022

GSK vaccine shows ‘exceptional’ efficacy against common lung infection RSV

The pharmaceutical giant’s vaccine was found to be 82.6 per cent effective in Phase III clinical trials

Evening Standard · Oct 14, 2022

Editorial: Florida surgeon general’s COVID vaccine ‘study’ is politics dressed up as science

This far into the pandemic, tens of millions of Americans have received mRNA COVID vaccines, following vast medical trials. The Centers for Disease Control and Prevention and the Food and Drug Administration continue to review the safety of the vaccines, part of what the CDC calls “the most intense safety…

Tribune News Service · Oct 14, 2022

Read news from The Economist, FT, and more,
with one subscription

Health officials warn of new Covid strain 'Omicron Spawn' as symptoms listed

The prevalence of BF.7 has doubled in the United States over the past two weeks, rising from 0.8% to 1.7%

Irish Mirror · Oct 14, 2022

Covid: Who can get an autumn booster jab and how do I book?

Booster vaccinations are being offered to everyone in England over the age of 50

The Independent UK · Oct 14, 2022

The FDA has officially declared a shortage of Adderall

The FDA has confirmed the nation is experiencing a shortage of Adderall after many pharmacies around the country have been unable to fill prescriptions and keep up with demand.

WEKU · Oct 14, 2022

Warning issued over "dangerously strong" batch of heroin on sale in Dumfries and Galloway

The NHS Specialist Drug and Alcohol Service became aware of it after “repeated medical interventions” in the Dumfries area

Daily Record · Oct 14, 2022

How to ease Covid jab side effect experienced by 92 per cent of people

From Friday, 12million more people are being asked to come in for another Covid injection

Wales Online · Oct 14, 2022

Dismay as key cholera vaccine is discontinued

Exclusive: halt to production of Shanchol vaccine alarms WHO amid ‘unprecedented’ global outbreaks

The Guardian - UK · Oct 14, 2022

China's zero-COVID policies save lives - but not livelihoods

China's ultra-strict COVID-19 curbs are taking a toll on businesses and jobseekers as Beijing stresses again and again the need to maintain its zero-tolerance approach to the virus, to save lives, if not livelihoods.

Reuters · Oct 14, 2022

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service · Oct 13, 2022

Baby formula disaster failed to dent Abbott Labs’ ESG score

Several months after the US government began investigating an Abbott Laboratories baby-formula plant for its connection to the deaths of at least two infants, the world’s most influential judge of corporate environmental, social and governance practices upgraded the company.

Benzinga · Oct 13, 2022

Psychedelics Stream: New Platforms And Apps Providing Up-To-Date Info & Resources

The growing acceptance of psychedelics as a source for treating health conditions and promoting wellbeing has led several companies and non-profit organizations worldwide to launch initiatives supporting those interested in accessing these therapies, ranging from programs on

The Independent UK · Oct 13, 2022

Biden administration extends COVID public health emergency

The Biden administration says the COVID-19 public health emergency will continue through Jan. 11 as officials brace for a spike in cases this winter

Benzinga · Oct 13, 2022

This Is What Whales Are Betting On Biogen

Someone with a lot of money to spend has taken a bearish stance on Biogen (NASDAQ:BIIB). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK · Oct 13, 2022

DC sues chemical manufacturer over pesticide pollution

The District of Columbia filed a lawsuit Thursday against Velsicol, claiming it violated the city's environmental laws by polluting a major waterway, the Anacostia River, and its surrounding environment for decades

ABC News · Oct 13, 2022

Paracetamol poisoning on the rise, TGA considers limiting how much people can buy

The medicines regulator is considering whether to put some restrictions on how paracetamol is sold because of concerns about its use in self-harm.

Salon · Oct 13, 2022

Fla. surgeon general's anti-vax warning

"This study is too flawed to be used to set policy on the mRNA vaccines in younger males," one expert said

Tribune News Service · Oct 13, 2022

Pfizer says booster lifts antibodies for omicron variants

Pfizer Inc. and its German vaccine partner said their booster tailored to the latest omicron variants raised more antibodies against the dominant strains of COVID-19 when compared with the original shot designed to fight the form of the virus.

Asharq Al-Awsat · Oct 13, 2022

Pfizer, BioNTech Find Updated COVID Booster Protects against Omicron in Trial

Pfizer and its German partner BioNTech said their COVID-19 vaccine booster, adapted for the BA.4 and the BA.5 subvariants of Omicron, generated a strong immune response and was well-tolerated in testing on humans. With the results, which the companies described as consistent with preclinical data, the partners are following up…

The Conversation · Oct 13, 2022

UK drug policy: how seizing passports will not stop illicit dug use

In an attempt to clamp down on recreational drug use, the British government recently set out a three-tier system for dealing with people caught in possession of illegal substances.

Dublin Live · Oct 13, 2022

Pharmaceutical giant Novartis to cut 400 Dublin jobs

Employees were informed of the phased cuts earlier today

1 … 123 124 125 126

People

Tedros Adhanom Ghebreyesus

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.